Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MPH | TSXV | CAD | Delayed | |
MPH | CBOE Canada | CAD | Real-time |
For the three months ended 31 March 2022, Medicure Inc revenues increased 16% to C$5.7M. Net income totaled C$482K vs. loss of C$1M. Revenues reflect Marketing & Distribution of Commercial Products segment increase of 37% to C$3.9M. Net Income reflects Selling/General/Admin Expense decrease of 48% to C$1.3M (expense), Finance (income) expense, net decrease of 84% to C$19K (expense).
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 5.72 | 6.8 | 4.92 | 5.09 |
Gross Profit | 4.03 | 3.78 | 2.88 | 3.04 |
Operating Income | 0.68 | 0.33 | -0.72 | -0.77 |
Net Income | 0.48 | 1.91 | -0.95 | -0.64 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 28.22 | 28.41 | 30.18 | 30.93 |
Total Liabilities | 9.48 | 10 | 13.13 | 13.71 |
Total Equity | 18.74 | 18.41 | 17.05 | 17.22 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -0.74 | 3.99 | 1.82 | 0.68 |
Cash From Investing Activities | -0.05 | -2.69 | -0.62 | -0.39 |
Cash From Financing Activities | -0.08 | -0.32 | -0.61 | -0.55 |
Net Change in Cash | -0.9 | 0.98 | 0.59 | -0.26 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review